Quoin Pharmaceuticals, Ltd. — POS AM Filings
8 POS AM filings on record
This page lists all POS AM filings submitted to the SEC by Quoin Pharmaceuticals, Ltd. (QNRX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Quoin Pharmaceuticals, Ltd. has filed 8 POS AM documents with the SEC since 2016. To view all SEC filings by Quoin Pharmaceuticals, Ltd., see the full filings list.
All
10-K
10-Q
144
20-F
20-F/A
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
6-K
6-K/A
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-4
F-4/A
F-6
FWP
POS AM
POS EX
PRE 14A
RW
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| POS AM | POS AM | 0001104659-25-029406 | Mar 28, 2025 | — |
| POS AM | POS AM | 0001410578-24-000363 | Mar 29, 2024 | — |
| POS AM | POS AM | 0001410578-23-000269 | Mar 15, 2023 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 | 0001213900-19-004888 | Mar 26, 2019 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1 | 0001213900-18-010588 | Aug 9, 2018 | — |
| POS AM | POST-EFFECTIVE AMENDMENT TO FORM F-1 | 0001213900-18-003264 | Mar 21, 2018 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 2 | 0001213900-17-008128 | Aug 1, 2017 | — |
| POS AM | POS AM | 0001144204-17-017381 | Mar 30, 2017 | — |